Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone add-on in acute mania
NCT00312494Phase 3Completed
- Sponsor
- Viatris
- Start
- Apr 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ziprasidone in bipolar I disorder (3 arms), sponsored by Viatris. Primary endpoint: Young Mania Rating Scale at 3 weeks. Started Apr 2006; status: completed.
02
Drugs
ziprasidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00312494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312494.